BECTON, DICKINSON AND COMPANY Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BECTON, DICKINSON AND COMPANY share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2017 was 186.00K shares, a 70.57% decline from fiscal 2016.
- BECTON, DICKINSON AND COMPANY share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2016 was 632.00K shares, a 29.78% decline from fiscal 2015.
- BECTON, DICKINSON AND COMPANY share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2015 was 900.00K shares.
- BECTON, DICKINSON AND COMPANY share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2013 was 1.51M shares, a 3.79% increase from fiscal 2012.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2017-09-30 | 186.00K shares 10-K · filed 2017-11-22 | |
| 2016-09-30 | 632.00K shares 10-K · filed 2016-11-23 | |
| 2015-09-30 | 900.00K shares 10-K · filed 2015-11-25 | |
| 2014-09-30 | 337.00K shares 8-K · filed 2015-03-13 | |
| 2013-09-30 | 1.51M shares 10-K · filed 2013-11-27 | |
| 2012-09-30 | 1.45M shares 10-K · filed 2012-11-21 | |
| 2011-09-30 | 2.93M shares 10-K · filed 2011-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |